These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22101984)

  • 41. Pim kinase-dependent inhibition of c-Myc degradation.
    Zhang Y; Wang Z; Li X; Magnuson NS
    Oncogene; 2008 Aug; 27(35):4809-19. PubMed ID: 18438430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MYC-driven malignant transformation of mature murine B cells requires inhibition of both intrinsic apoptosis and p53 activity.
    Högstrand K; Grandien A
    Eur J Immunol; 2019 Mar; 49(3):375-385. PubMed ID: 30281155
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of c-myc and CD45 in spontaneous and anti-receptor-induced apoptosis in adult murine B cells.
    Scott DW; Lamers M; Köhler G; Sidman CL; Maddox B; Carsetti R
    Int Immunol; 1996 Sep; 8(9):1375-85. PubMed ID: 8921415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated Mdm2 expression induces chromosomal instability and confers a survival and growth advantage to B cells.
    Wang P; Lushnikova T; Odvody J; Greiner TC; Jones SN; Eischen CM
    Oncogene; 2008 Mar; 27(11):1590-8. PubMed ID: 17828300
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells.
    Wang J; Anderson PD; Luo W; Gius D; Roh M; Abdulkadir SA
    Oncogene; 2012 Apr; 31(14):1794-803. PubMed ID: 21860423
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis.
    Zhao B; Liu L; Mao J; Zhang Z; Wang Q; Li Q
    Cell Death Dis; 2018 Feb; 9(3):307. PubMed ID: 29472550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PIM1: a promising target in patients with triple-negative breast cancer.
    Zhao W; Qiu R; Li P; Yang J
    Med Oncol; 2017 Aug; 34(8):142. PubMed ID: 28721678
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors.
    Mikkers H; Nawijn M; Allen J; Brouwers C; Verhoeven E; Jonkers J; Berns A
    Mol Cell Biol; 2004 Jul; 24(13):6104-15. PubMed ID: 15199164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis.
    Michalak EM; Jansen ES; Happo L; Cragg MS; Tai L; Smyth GK; Strasser A; Adams JM; Scott CL
    Cell Death Differ; 2009 May; 16(5):684-96. PubMed ID: 19148184
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice.
    Kelly PN; Grabow S; Delbridge AR; Strasser A; Adams JM
    Blood; 2011 Dec; 118(24):6380-6. PubMed ID: 21998213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MYC expression and distribution in normal mature lymphoid cells.
    Cattoretti G
    J Pathol; 2013 Feb; 229(3):430-40. PubMed ID: 23165652
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transforming growth factor-beta1 sensitivity is altered in Abl-Myc- and Raf-Myc-induced mouse pre-B-cell tumors.
    Letterio J; Rudikoff E; Voong N; Bauer SR
    Stem Cells; 2006 Dec; 24(12):2611-7. PubMed ID: 16945999
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Essential role of phospholipase C gamma 2 in early B-cell development and Myc-mediated lymphomagenesis.
    Wen R; Chen Y; Bai L; Fu G; Schuman J; Dai X; Zeng H; Yang C; Stephan RP; Cleveland JL; Wang D
    Mol Cell Biol; 2006 Dec; 26(24):9364-76. PubMed ID: 17030619
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Histone H2AX suppresses translocations in lymphomas of Eμ-c-Myc transgenic mice that contain a germline amplicon of tumor-promoting genes.
    Fusello A; Horowitz J; Yang-Iott K; Brady BL; Yin B; Rowh MA; Rappaport E; Bassing CH
    Cell Cycle; 2013 Sep; 12(17):2867-75. PubMed ID: 23966158
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma.
    Wang J; Kim J; Roh M; Franco OE; Hayward SW; Wills ML; Abdulkadir SA
    Oncogene; 2010 Apr; 29(17):2477-87. PubMed ID: 20140016
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of Leukemia-Inducing Genes Using a Proto-Oncogene/Homeobox Gene Retroviral Human cDNA Library in a Mouse In Vivo Model.
    Jang SH; Lee S; Chung HY
    PLoS One; 2015; 10(11):e0143240. PubMed ID: 26606454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers.
    Calado DP; Sasaki Y; Godinho SA; Pellerin A; Köchert K; Sleckman BP; de Alborán IM; Janz M; Rodig S; Rajewsky K
    Nat Immunol; 2012 Nov; 13(11):1092-100. PubMed ID: 23001146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Msh2-dependent DNA repair mitigates a unique susceptibility of B cell progenitors to c-Myc-induced lymphomas.
    Nepal RM; Tong L; Kolaj B; Edelmann W; Martin A
    Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18698-703. PubMed ID: 19837692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suppression of B-cell lymphomagenesis by the BH3-only proteins Bmf and Bad.
    Frenzel A; Labi V; Chmelewskij W; Ploner C; Geley S; Fiegl H; Tzankov A; Villunger A
    Blood; 2010 Feb; 115(5):995-1005. PubMed ID: 19965635
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kinase PIM1 promotes prostate cancer cell growth via c-Myc-RPS7-driven ribosomal stress.
    Zhang C; Qie Y; Yang T; Wang L; Du E; Liu Y; Xu Y; Qiao B; Zhang Z
    Carcinogenesis; 2019 Mar; 40(1):52-60. PubMed ID: 30247545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.